China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Significant Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 455,300 shares, an increase of 744.7% from the August 31st total of 53,900 shares. Currently, 13.1% of the shares of the company are short sold. Based on an average daily volume of 651,400 shares, the short-interest ratio is presently 0.7 days.

China SXT Pharmaceuticals Stock Performance

Shares of China SXT Pharmaceuticals stock opened at $0.60 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.60 and a quick ratio of 1.51. The firm has a 50-day moving average of $0.86 and a 200-day moving average of $1.12. China SXT Pharmaceuticals has a 52-week low of $0.53 and a 52-week high of $6.39.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.